Using previously curated datasets of liver cancer patients [42], we found that gene sets expressed in hepatocellular carcinoma patients with poorer prognosis become predominantly downregulated in SAMD1 KO HepG2 cells, while genes that are expressed in HCC patients with better survival become upregulated (Figure 2f). The gene discussed is SAMD1; the disease is hepatocellular carcinoma.